DOP2010000066A - Formas polimorfas de (s)-2-((4- benzofuranil) carbonilaminometil)-1-((4-metil-5-(4- fluorofenil)tiazolil) carbonil)piperidina - Google Patents

Formas polimorfas de (s)-2-((4- benzofuranil) carbonilaminometil)-1-((4-metil-5-(4- fluorofenil)tiazolil) carbonil)piperidina

Info

Publication number
DOP2010000066A
DOP2010000066A DO2010000066A DO2010000066A DOP2010000066A DO P2010000066 A DOP2010000066 A DO P2010000066A DO 2010000066 A DO2010000066 A DO 2010000066A DO 2010000066 A DO2010000066 A DO 2010000066A DO P2010000066 A DOP2010000066 A DO P2010000066A
Authority
DO
Dominican Republic
Prior art keywords
fluorophenyl
piperidine
methyl
carbonilaminometil
tiazolil
Prior art date
Application number
DO2010000066A
Other languages
English (en)
Inventor
Leanda Jane Kindon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DOP2010000066A publication Critical patent/DOP2010000066A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevas formas cristalinas de (s)-2-((4- benzofuranil) carbonilaminometil)-1-((4-metil-5-(4- fluorofenil)tiazolil) carbonil)piperidina, metodos para su preparación y uso en medicina antagonista receptor de orexina.
DO2010000066A 2007-09-13 2010-02-26 Formas polimorfas de (s)-2-((4- benzofuranil) carbonilaminometil)-1-((4-metil-5-(4- fluorofenil)tiazolil) carbonil)piperidina DOP2010000066A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0717882.5A GB0717882D0 (en) 2007-09-13 2007-09-13 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
DOP2010000066A true DOP2010000066A (es) 2010-04-15

Family

ID=38658914

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000066A DOP2010000066A (es) 2007-09-13 2010-02-26 Formas polimorfas de (s)-2-((4- benzofuranil) carbonilaminometil)-1-((4-metil-5-(4- fluorofenil)tiazolil) carbonil)piperidina

Country Status (22)

Country Link
US (1) US20100286201A1 (es)
EP (1) EP2190842A1 (es)
JP (1) JP2010539133A (es)
KR (1) KR20100057035A (es)
CN (1) CN101801968A (es)
AR (1) AR068414A1 (es)
AU (1) AU2008297126A1 (es)
BR (1) BRPI0816757A2 (es)
CA (1) CA2699472A1 (es)
CL (1) CL2008002688A1 (es)
CO (1) CO6260068A2 (es)
CR (1) CR11306A (es)
DO (1) DOP2010000066A (es)
EA (1) EA201070361A1 (es)
GB (1) GB0717882D0 (es)
MA (1) MA31692B1 (es)
MX (1) MX2010002895A (es)
PE (1) PE20090639A1 (es)
TW (1) TW200927748A (es)
UY (1) UY31337A1 (es)
WO (1) WO2009034133A1 (es)
ZA (1) ZA201001083B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120101110A1 (en) * 2010-10-26 2012-04-26 Sangamesh Badiger Diaza-spiro[5.5]undecanes
WO2017194548A1 (en) 2016-05-10 2017-11-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE293101T1 (de) * 2000-06-16 2005-04-15 Smithkline Beecham Plc Piperidine zur verwendung als orexin rezeptor antagonisten
US20060178307A1 (en) * 2005-01-26 2006-08-10 The Regents Of The University Of California Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor

Also Published As

Publication number Publication date
AR068414A1 (es) 2009-11-18
CO6260068A2 (es) 2011-03-22
CA2699472A1 (en) 2009-03-19
PE20090639A1 (es) 2009-06-25
CL2008002688A1 (es) 2009-11-27
MA31692B1 (fr) 2010-09-01
EP2190842A1 (en) 2010-06-02
MX2010002895A (es) 2010-04-01
ZA201001083B (en) 2010-10-27
TW200927748A (en) 2009-07-01
CN101801968A (zh) 2010-08-11
US20100286201A1 (en) 2010-11-11
GB0717882D0 (en) 2007-10-24
EA201070361A1 (ru) 2010-08-30
AU2008297126A1 (en) 2009-03-19
BRPI0816757A2 (pt) 2015-03-17
CR11306A (es) 2010-04-20
WO2009034133A1 (en) 2009-03-19
UY31337A1 (es) 2009-04-30
JP2010539133A (ja) 2010-12-16
KR20100057035A (ko) 2010-05-28

Similar Documents

Publication Publication Date Title
BRPI0924183A2 (pt) inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso
SMT201600388B (it) Ligandi leganti opsina, composizioni e metodi d'uso
DK1931346T3 (da) Trazodonsammensætning til indgivelse en gang om dagen
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
BRPI0923500A2 (pt) uso e composição farmacêutica compreendendo agonista ou modulador do receptor s1p, e kit.
BRPI1010621A2 (pt) derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
ATE483707T1 (de) 2-cyclopropylthiazolderivate
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0822929A2 (pt) Composições compreendendo derivados de álcool benzílico e também compostos ativos antimicrobianos
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
EA201200506A1 (ru) СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-(4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ)БЕНЗОЛА
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0818003A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BRPI0915120A2 (pt) composto derivado de oxima, uso do referido composto e composição farmacêutica
BRPI0915552A2 (pt) derivados de ciclosporina, seu uso e sua composição farmacêutica
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0808172A2 (pt) Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso.
BRPI0812942A2 (pt) Composto, composição farmacêutica e uso de um composto